Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Recommendation of “Buy” by Analysts

Privia Health Group, Inc. (NASDAQ:PRVA) has earned a consensus rating of “Buy” from the seventeen research firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation, fourteen have given a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $25.19.

A number of equities research analysts have weighed in on PRVA shares. Barclays upped their target price on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Stephens reiterated an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a research report on Thursday, January 2nd. JPMorgan Chase & Co. increased their price objective on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Needham & Company LLC began coverage on Privia Health Group in a research report on Friday, January 10th. They set a “buy” rating and a $25.00 price objective for the company. Finally, JMP Securities reiterated a “market outperform” rating and set a $26.00 price objective on shares of Privia Health Group in a research report on Friday, February 14th.

Institutional Trading of Privia Health Group

Several large investors have recently added to or reduced their stakes in PRVA. Nordea Investment Management AB increased its stake in shares of Privia Health Group by 33.1% in the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock worth $6,953,000 after acquiring an additional 86,910 shares during the last quarter. Victory Capital Management Inc. increased its stake in shares of Privia Health Group by 402.9% in the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock worth $3,260,000 after acquiring an additional 143,446 shares during the last quarter. Franklin Resources Inc. increased its stake in shares of Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after acquiring an additional 28,480 shares during the last quarter. Barclays PLC increased its stake in shares of Privia Health Group by 240.3% in the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after acquiring an additional 158,188 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Privia Health Group by 8.4% in the third quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock worth $3,430,000 after acquiring an additional 14,641 shares during the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Price Performance

PRVA opened at $24.06 on Thursday. The company has a market capitalization of $2.89 billion, a price-to-earnings ratio of 240.62, a price-to-earnings-growth ratio of 3.47 and a beta of 0.87. Privia Health Group has a 1-year low of $15.92 and a 1-year high of $25.67. The business has a 50 day moving average price of $22.20 and a two-hundred day moving average price of $20.52.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.